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1. Introduction 
Dehydrogenases are a group of biological catalysts (enzymes) that mediate in biochemical 
reactions removing hydrogen atoms [H] instead of oxygen [O] in its oxido-reduction 
reactions. It is a versatile enzyme in the respiratory chain pathway or the electron transfer 
chain. T. Turnberg discovered this group of enzymes between1900-1922. Several 
dehydrogenases are present in tissues of humans, plants and micro-organisms having 
enormous biochemical interests. As a result of the polymorphic nature of this enzyme, it is 
pertinent therefore to limit our interest on the different functions of Lactate dehydrogenase 
in the diagnosis and treatment of malaria. Lactate dehydrogenase, an oxidoreductase [EC 
1.1.1.27] exists in different forms in different tissues possessing different subunits as a multi-
enzyme complex called isoenzyme. It is the last enzyme of the glycolytic sequence or 
pathway essential for ATP generation. The enzyme, 17β-Hydroxysteroid dehydrogenase 
exists in at least fourteen isoforms in tissues involved in the biosynthesis of estrogenic and 
androgenic steroids. Lactate dehydrogenase is a tetrameric enzyme, but only two distinct 
subunits have been found; those designated H for heart (myocardium) and M for muscle. 
These two subunits are combined in five different ways. The lactate dehydrogenase 
isoenzymes, subunit compositions and major locations are shown below. 
Following myocardial infarction (MI), the serum levels of LDH rise within 24-28 hrs, 
reaching a peak by 2-3 days and return to normal in 5-10 days. Especially diagnostic is a 
comparison of the LDH1/LDH2 ratio. Normally, the ratio is less than 1. A reversal of the 
ratio is referred to as “flipped LDH”. Following an acute myocardial infarction, the flipped 
ratio will appear in 12-24 hours and it is definitely present by 48 hours in over 80% of cases. 
Also important, is the fact that, persons suffering from chest pain due to angina only, will 
not likely have LDH altered levels. 
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Type  composition  Location 
LDH1  HHHH  Found in the heart and red blood cells 
and Is 17%-27% of the normal serum 
level.  
LDH2  HHHM  Found in the heart and red blood cells 
and 27%-37% of the normal serum level 
LDH3  HHMM  Found in a variety of organs and is 
18%-25% of the normal serum level. 
LDH4  HMMM  Found in a variety of organs and is 3%-
8% of the normal serum level. 
LDH5  MMMM  Found in liver and skeletal muscles and 
is 0%-5% Of the normal serum level.  
Table 1. Subunit compositions and major locations of Lactate Dehydrogease Isoforms 
2. Measurement of parasite lactate dehydrogenase (pLDH) activity of 
plasmodium falciparum  
Malaria is the most lethal parasitic disease in the world, annually affecting approximately 
500 million people and resulting in 800,000 deaths, mostly in Africa and Sub-Saharan 
countries [1]. Some countries, for example Brazil registered more than 306,000 deaths in 
2009, most of which were in the Amazonian region [2]. In Africa, the figures may be higher 
due to endemic nature of the infection. Transmission occurs through the bite of the female 
anopheles mosquitoes infected with the parasite of which there are five species affecting 
humans. Plasmodium falciparum is the most pathogenic species and may cause severe 
malaria and death in non-immune individuals, especially children under five years [3].Drug 
resistant malaria parasites have emerged and has resulted in treatment failures. This 
resistance might be as a result of mutation at the active sites of drug targets or from 
biochemical changes in the drug receptors [4]. 
Plasmodium falciparum is a significant cause of morbidity and mortality in travelers to 
areas where the parasite is endemic. Non –specific manifestations may equally result in 
failure to recognize malaria until autopsy, when it is often too late to obtain blood for 
microscopic evaluation, which has been in use for years for the diagnosis of malarial 
parasitemia. The Plasmodium falciparum lactate enzyme (pLDH) has been considered, a 
potential molecular target for antimalarials. This is an enzyme assay for the detection of 
Plasmodium falciparum, employed in the assessment of malarial parasitism. The enzyme 
assay is based on the observation that Lactate dehydrogenase(LDH) enzyme of P. falciparum 
has the ability to rapidly use 3-acetylpyridine dinucleotide(APAD) as a co-enzyme instead 
of NAD in the reaction leading to the formation of pyruvate from lactate. Human red blood 
cells’ LDH carries out this reaction at very low rate in the presence of APAD. The measured 
development of APADH leads to the formation of a product that could establish the basis of 
an assay that detects the presence of P. falciparum from in vitro cultures at parasitemic levels 
of 0.02 %. Lactate dehydrogenase is the most abundant enzyme expressed by P. falciparum. 
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A correlation between levels of parasitemia and the activity of parasite LDH from patients 
with malaria is worthwhile. The serum assay for PLDH is followed up to monitor the level of 
PLDH in a patient with cerebral malaria prior to antimalarial therapy and also during recovery 
period. It is evident that measurement of pLDH has a strong correlation with malarial 
parasitemia and can follow a method that can be developed into a simple test for the detection 
of Plasmodium falciparum as an assessment of plasmodium parasitemia. In malarial falciparum 
parasitemia, LDH does not persist in blood, but clears about the time as the parasite, following 
successful treatment. The lack of antigen persistence after treatment makes the pLDH test 
useful in predicting treatment failure. In this respect, pLDH is similar to pGluDH. LDH for 
P.vivax, P.ovale, and P. malariae exhibit 90-92% identity to pLDH from P. falciparum. 
3. Functions of inhibitors of parasite lactate dehydrogenase (pLDH) as 
potential antimalarial agents 
The plasmodium falciparum lactate dehydrogenase enzyme (Pf LDH), has been considered a 
potential molecular target to antimalarials due to this parasite dependence on glycolysis for 
energy production by catalyzing the reduction of pyruvate to lactate. It has been a routine 
activity among drug designers for malarial infestation to embark on the screening of analogs 
to NADH(an essential cofactor) to pLDH.The continued search for new molecular targets for 
drug design is an endless search, since the introduction of the quinolones in malaria therapy. 
Chloroquine interacts specifically with PfLDH in the NADH binding pocket, occupying a 
position similar to that of the adenyl ring cofactor, hence acting as a competitive inhibitor for 
this critical glycolytic enzyme [5,6,7,8]. Analogs of NADH have been identified as new 
potential inhibitors to PfLDH[9].  Computational studies have been undertaken to recognize 
the potential binding of selected compounds to the pLDH active site. This was analyzed using 
Motegro Virtual Docker Software. The researchers selected fifty (50) compounds based on 
their similarity to NADH. The compounds with the best bonding energies included: 
itraconazole, atorvastatin and posaconazole. These were tested against P. falciparum , 
chloroquine resistant blood parasites. All these compounds proved to be active in two 
immunoenzymatic assays performed in parallel using monoclonals specific to pfLDH or a 
histidine rich protein 2 (HRP 2). The IC 50 values for each drug in both tests are similar; values 
were lowest for posaconazole (< 5µM) and were 40-and 100-fold less active than chloroquine. 
The compounds so tested reduced P. berghi parasitemia in treated mice, in comparison to 
untreated control. The drug itraconazole is the least active compound. Posaconazole is an 
inhibitor of ergosterol biosynthesis [10]. In this study, it was the most active drug against P. 
falciparum. It is also, the most effective compound against murine malaria caused by P. berghei 
and was the most promising agent in vitro and in vivo. Itraconazole is normally acquired as a 
tablet, causes a strong inhibition of P. falciparum growth in vitro and is partially active against 
P. berghei. The results of these trials according to the authors proved that molecular docking 
studies are important in the strategy for discovering new antimalarial drugs. This approach is 
more practical and less expensive than discovering novel compounds that require studies on 
human toxicology. The parasite enzyme, lactate dehydrogenase has recently received a great 
deal of attention, since it may constitute a valid therapeutic target for diseases such as malaria 
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and cancer. Because the LDH enzymes found in P.vivax, P. ovale and P.malariae, all exhibit 90% 
identity to PfLDH; It would be desirable to have new anti-pLDH drugs particularly, ones that 
are effective against P. falciparum, the most virulent species of human malaria. Most invasive 
tumor phenotypes show a metabolic switch (Warburg effect) from oxidative phosporylation to 
an increased anerobic glycolysis by promoting an up-regulation of the human isoform-5 of 
lactate dehydrogenase (hLDH-5 or LDH-A), which is normally present in muscles and liver. 
Hence, inhibition of hLDH-5 may constitute an efficient way to interfere with tumor growth 
and invasiveness.  
4. New enzymatic assay using parasite ldh in diagnosis of malaria in 
Kenya 
The biochemical basis for this assay is on the fact that human red blood cells do not utilize 
APAD in the metabolism of glucose. The study subjects were of three different categories: 
the healthy non-infected individuals staying out of malaria endemic area( controlled GP-
1).The non-symptomatic and parasitemic healthy individuals living in endemic regions 
(both field study –GP 2).The non-parasitemic and parasitemic symptomatic individuals 
living in endemic region (both clinical study Group 3).In the clinical studies, thin smear 
microscopy gave the highest sensitivity as 75.6 % for plasma, while the highest specificity 
was 71.4 %. For red blood cells, the highest sensitivity was 78.4% while specificity was 80 %. 
In field trials, the highest sensitivity was 89 %) using thin smear microscopy, where as the 
specificity was 45% for the plasma cut off, using thick smear. For red blood cells, the highest 
sensitivity was 79% while the specificity was 66.7%. The variations in sensitivity and 
specificity of this assay in comparison to microscopy is a strong indication that pLDH may 
even be measuring sequestered parasites that cannot be visualized by microscopy. The 
results of the study validates the use of pLDH as an alternative objective test for malarial 
diagnosis against microscopy.  
5. Malaria antigen detection tests  
There are currently over twenty (20) such tests commercially available (WHO product 
testing, 2008) and these consist of a group of commercially available tests that allow rapid 
diagnosis of malaria by unskilled laboratory traditional techniques. The first malaria antigen 
suitable as target for Rapid Diagnostic Tests (RDTs) was a soluble glycolytic enzyme, 
Glutamate dehydrogenase. None of the current tests is as sensitive as a thick blood film. A 
major drawback in the use of all dipstick methods is that the result is essentially qualitative. 
In many endemic areas of tropical Africa; however, the quantitative assessment of 
parasitemia is important as a large percentage of the population will test positive. An 
accurate diagnosis of malaria is becoming more and more important in view of the 
increasing resistance of Plasmodium falciparum and the high price of alternatives to 
chloroquine. The enzyme pGluDH (parasite Glutamate Dehydrogenase) does not occur in 
the host red blood cells and was regarded as a marker enzyme for Plasmodium species. The 
malaria marker enzyme test is suitable for routine work and it’s now a standard in most 
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nations afflicted with malaria. The presence of pGluDH is known to represent parasite 
viability, and a rapid diagnostic test using pGluDH as antigen would have the ability to 
differentiate live and dead organisms. It is possible to note that a complete RDT with 
pGluDH as antigen has been developed in China. Glutamate dehydrogenases are 
ubiquitous enzymes that occupy an important branch point between carbon and nitrogen 
metabolisms. Both nicotinamide adenine dinucleotide[ (NAD)EC 1.4.1.2] and nicotinamide 
adenine dinucleotide phosphate (NADP) dependent GluDH [EC1.4.1.4] enzymes are present 
in plasmodia. The NAD-dependent GluDH is relatively unstable and not useful for 
diagnostic purposes. Glutamate dehydrogenase provides an oxidizable carbon source used 
in production of energy as well as a reduced electron carrier, NADH. Glutamate is a 
principal donor to other amino acids in subsequent transamination reactions. The multiple 
roles of glutamate in nitrogen balance, make it a gateway between free ammonia and the 
amino groups of most amino acids. The GluDH activity in P. vivax, P.ovale and P. malariae 
has been tested, but given the importance of GluDH as a branch point enzyme, every cell 
must have a high concentration of GluDH. It is well known that enzymes with high 
molecular weights like GluDH have many isoenzymes which allow strain differentiation 
(given the right monoclonal antibody).The host produces antibodies against the parasite 
enzyme, indicating a low sequence identity.  
6. New therapeutic approaches for treatment of plasmodium falciparum 
The antimalarial treatment so far recommended for P. falciparum consists of drug 
combinations containing Artemisinin derivatives (ACT) known as artemisinin combination 
therapy with other antimalarials, including quinolone compounds such as Amodiaquine 
and Mefloquine. The mechanism of action of the quinolones involve the inhibition of 
hematin polymerization, thus intoxicating the parasite with the ferriprotoporphyrin groups 
generated by hemoglobin degradation. Other antimalarials used in the ACT therapy 
include-Pyrimethamine and proguanil, which inhibit the tetrahydrofolic acid cycle 
(tetrahydropterate reductase, limiting the formation of folic acid, an important cofactor in 
DNA biosynthesis. Despite the arsenal of drugs available for malaria treatment, the disease 
remains a worldwide public health problem. P. falciparum develops resistance under 
selected drug pressure. Plasmodium vivax is the most prevalent human malaria parasite 
world over and has been shown to be resistant to chloroquine, including in Brazil and other 
countries where malaria is endemic. Various efforts have been made to develop new drugs 
(antimalarials), but resistance to drugs has limited the search. The continued search for new 
molecular targets for drug design has broadened the therapeutic arsenal and strategies to 
fight drug resistance in human malarial infestation. 
7. Three new parasite ldh (pan-pLDH) tests for diagnosis of 
uncomplicated malaria 
Since Charles Laveran first visualized the malaria parasite in 1880; the mainstay of malaria 
diagnosis has been the microscopic examination of blood smear. It is the main economic, 
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most preferred and reliable diagnosis using two types of blood films, which is amenable to 
the four species of malaria parasite. These two types of films are (a) the thin blood film 
which is similar to the usual blood films, which allows species to be identified because they 
can be visualized and the appearance of the parasites are much more distorted.(b)the thick 
film from which an experienced microscopist can detect parasite levels or parasitemia down 
to levels as low as 0.0000001% of red blood cells. Diagnosis of species can be difficult 
because, the early trophozoites (“ring form”) of all four species look identical and never 
possible to diagnose the species on the basis of simple ring form. The success of the method 
above requires well trained staff, quality equipment and supervision. The scarcity of these 
facilities within malaria endemic areas becomes limiting. In sub-Saharan Africa and some 
other areas, clinicians often have to rely on clinical signs and symptoms for diagnosis and in 
some areas where increasing emphasis is laid on home based management , malaria diagnosis 
is often equated[11] with fever. It is to be noted that such presumptive treatment without 
laboratory confirmation could contribute to the development of drug resistance[11]. Today, an 
alternative method to the blood film diagnosis approach is the rapid diagnostic test (RDTs), 
recommended by WHO, where reliable microscopy is not reliable or available. Rapid 
diagnostic tests (RDTs) are antigen detection tests, which are simple to use and interpret, 
although the tests also use peripheral blood. The most commonly used RDTs, is the histidine-
rich protein 2 (HRP 2), produced by trophozoites and young gametocytes of plasmodium 
falciparum. HRP 2 test has been the most widely evaluated to date test, and has shown 
consistently high sensitivity. The limitation of this test is that RDTs detect P. falciparum only 
and can remain positive for several weeks after antimalarial treatment. Besides these, a study 
to assess the diagnostic capabilities of three parasite lactate dehydrogenase (pan- LDH)-  
,Vistapan® ,Carestat™ and Parabank® were conducted in Uganda. Similarly, a histidine- rich 
protein 2 (HPR 2) test, Paracheck-Pf® and a Geimsa-stained blood film were performed with 
pfLDH tests for outpatients. A total of 460 patients were recruited for the exercise, 248 had 
positive blood films and 212 with negative blood films. Plasmodium falciparum was present in 
95% of infections. Sensitivity of the tests above 90% was shown by two pLDH tests-Carestart 
(96.5%) and Vistapan (91.9%) and sensitivity above 90% by Parabank (94.3%) and Carestart 
(91.5%). The benefits of these tests when compared with the previous gold standard for 
laboratory confirmation of malaria diagnosis which is a peripheral blood film examined 
microscopically shows the high specificity and validity of the tests.  
An alternative diagnostic method to the rapid diagnostic test (RTD), recommended by 
WHO, where reliable microscopy is not available. RTDs are antigen detection tests, which 
are simple to use and interpret and also use peripheral blood. The most commonly used 
RTD detects histidine -rich protein 2 (HRP2), produced by trophozoites and young 
gametocytes of Plasmodium falciparum. HRP 2 tests have been the most widely evaluated to 
date and show high sensitivity. However, they are limited in that they detect P. falciparum 
only and can remain positive for several weeks after successful treatment[12,13].  
The second type of RTD detects the malaria antigen parasite lactate dehydrogenase (pLDH), 
an enzyme produced in the glycolytic cycle of the asexual stage of all species of 
Plasmodium. Parasite lactate dehydrogenase( pLDH) are produced only by viable parasites, 
 
Functions of Dehydrogenases in Health and Disease 171 
thus being cleared from the blood stream more rapidly after treatment, resulting in test 
becoming negative more quickly. There is no doubt that these characteristics suggest that 
pLDH tests could be used with more confidence for malaria diagnosis at the peripheral 
level. The development of several new pLDH monoclonal antibodies by Flow Inc. has 
enabled the production of a new generation of pLDH tests. These characteristics suggest 
that pLDH tests could be used with more confidence for malaria diagnosis at the peripheral 
level [14]. For confident diagnosis of malaria in routine outpatient department conditions, a 
sensitivity of more than 90% is crucial and this has been achieved by both Carestart and 
Vistapan. The pLDH tests have also demonstrated desirable qualities that could reduce the 
possibility of patients without malaria being given antimalarials, which may therefore 
reduce drug pressure, a major concern at a time when Artemesinin combination therapy 
(ACTs) are being introduced in Africa. The validation of these tests for malaria diagnosis 
involves many stages from the selection of site, enrolment of patients, sample size, study 
procedures, laboratory procedures, study outcomes, analysis and results. The validity of the 
tests after all these procedures must be rated from 90% and above. From the validity tests 
carried out by some researchers, Carestart had estimates for all validity parameters greater 
than 90%. Vistapan and Carestart were also sensitive as Paracheck Pf (p=0.14 and p=0.38) 
respectively. Parabank was less sensitive than all other tests (P<0.001 for each comparison). 
There was no significant difference between the three pLDH tests, but Parabank had a 
higher specificity compared with Paracheck Pf (P=0.02) for P. falciparum detection. In the 
study, the ages of patients were taken into consideration. Sensitivity decreased with older 
age for both Vistapan (97.4%) for the under fives versus 85.7%, P<0.011 and Parabank 
(95.4%) for the under fives versus 73.1%, P<0.001. Three tables were used to summarize the 
results of a study conducted in Mbarara Regional Hospital in Uganda, in a mesoendemic 
area of malaria transmission. These results are shown in tables 2, 3 and 4 respectively. 
7.1. Materials and methods 
The first approach is to select a site, which should be a highly malarial infested zone. 
7.2. Enrolment for the study. 
Patients from the outpatient department were systematically screened for symptoms 
suspected to be malaria and referred to the research clinic. Inclusion criteria were a clinical 
suspicion of malaria; weight≥ 5kg; resident in Mbarara Municipality available for two weeks 
follow up period; and signed informed consent from the study subjects or their legal 
guardians. Exclusion criteria were signs of severe or complicated malaria [15b], signs of 
severe disease; and women with visible pregnancy or suspicion of pregnancy based on the 
assessment of the last normal menstrual period.  
7.3. Sample size 
The required number of patients with positive blood film was calculated using an estimated 
sensitivity of the RDTs of 90%, an alpha error of 0.05 and a precision of 6%. This number (n-
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96) was doubled to permit a stratified analysis by age group (0--4 and ≥5 years. The same 
parameters were used to calculate the required number of patients with a negative blood 
film, thus giving a final minimum sample size of 200 blood-film-positive and 200 blood –
film –negative patients.  
7.4. Study procedures 
On the day of inclusion, demographic and clinical information were recorded, and a 
thick/thin blood film and the four rapid tests (Vistapan, Carestart, Parabank , and 
Paracheck-Pf) were performed. Women with positive pregnancy test and hyperparasitemic 
patients (P. falciparum›250,000 parasites/µl) were given quinine and excluded from further 
follow up. All other patients with positive blood film received an artemether-lumefantrine( 
Coartem®, Norvatis Pharma AG,Bassel,Switzerland), six –dose regimen under directly 
observed therapy. This treatment modality have been shown to be very efficacious with a 
prompt reversion to a negative [16] blood film after treatment. Patients receiving Coartem 
were asked to return to the Clinic on the third, seventh and 14th day after inclusion to repeat 
the blood film and all RDTs 
7.5. Laboratory procedures 
Blood films and rapid tests were performed from the same finger-prick blood. Blood films 
were dried, thin films fixed in methanol, and both films stained with 3% Giemsa for 45 
minutes. Smears were read by experienced technicians, counting parasites against 200 or 500 
white blood cells (WBC) or 200 high power fields before declaring a blood slide negative. 
The parasite density per micro-liter was calculated by multiplying the asexual parasite 
count by 8000 and dividing by the number of WBC counted [17].Plasmodium species were 
confirmed on the thin film and slides with mixed infections had only P.falciparum 
monoinfection, had the asexual density per microliter calculated as for P.falciparum. 
Gametophytes were recorded with species identification where possible. All inclusion slides 
were blinded and double read, with a third reading performed in case of discordance, ie; 
positive/negative discordance for asexual stages; asexualdensity discordance (difference in 
parasitemia≥50%);positive/negative gametocyte discordance. Twenty percent of the follow-
up visit slides were also blinded and double read. External quality control of 290 inclusion 
slides was performed by Shokia Malaria Research Unit, Thailand, giving Mbarara 
laboratory, a sensitivity of 95.5% and a specificity of 100%. All RDTs were performed and 
interpreted according to the manufacture’s instructions. Each test result was interpreted by 
two independent health care providers blind to the result of the blood film and reading 
according to a rota to avoid observer bias. The first reading was performed at the time 
specified by the manufacturer (15 min after preparation for Paracheck Pf and Parabank and 
20 mins for Carestart and Vistapan. The second reading was performed within 15 min of the 
first one. Discordant results were read by the laboratory supervisor for a definitive result. 
Each reader also classified the test as either invalid or doubtful. A doubtful test was defined 
as a test for which the reader was not sure if there was any indication of a line present. At 
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the end of the study, two test readers and two laboratory technicians involved in preparing 
the tests completed a questionnaire concerning the ease of use and interpretation of each 
test. 
Analysis. All data were either recorded directly or transcribed from source data forms to an 
individually numbered case report form (CRF). Data were double entered and validated 
using EpiData version 3.1(EpiData Association,Odense, Denmark)and analysed using Stata 
9.1 (Stata Corp. college station,TX,USA).The study profile and base-line characteristics were 
summarized, including comparative tests between age groups (x 2 test ,Ma-Whitey U test). 
The validity for each test was calculated overall and then stratified by age group, level of 
parasitemia(parasites/µl 1---99,≥100,≥200,≥500), presence/absence of fever, duration of 
illness(0—2vs.3 days and above) and a history of taking antimalarials, using comparative 
tests( x 2 test, Mann-Whitney U test) to compare differences between groups. Kappa 
statistics were calculated for iter-reader reliability for each test on the day of diagnosis. A 
test was considered as reliable if k ≥ 0.8. Univariable and multivariate analyses were 
performed to investigate the association between explanatory factors and the test remaining 
positive at each follow- up visit. 
Results. Demographical and Parasitological characteristics of study subjects. 
Between 26 April and 27th July, 2005, 485 patients from the out-patient department were 
screened. Nine were ineligible (three had severe illness, five were non-residents and one 
was not in the appropriate age group after completion of recruitment in the under fives. 
Sixteen patients did not consent to participate in the study; 239 under fives and 221 aged 5 
years and above. The mean age was 12 years(SD 13years;Table 2). There were 248 positive 
blood films with P. falciparum monoinfections(93.6%), P. malariae monoinfections(2.4%), P. 
falciparum+ P. malariae mixed infections(0.8%) and P. falciparum+ P. vivax mixed 
infections(0.8%). Of the 212 negative films, nine had gametocytes present. Parasitological 
characteristics of positive subjects are given in Table 2. Slides positive with P. falciparum 
had higher parasite densities than those of the other two species. 
Validity of RDTs. 
Only Carestart had estimates for all validity parameters greater than 90% (Table 3). Vistapan 
and Carestart were as sensitive as Paracheck-Pf(P=0.14 and P=0.38 respectively. Parabank 
was less sensitive than all other tests (P‹0.001 for each comparison). There was no significant 
difference in specificity between the three pLDH tests, but Parabank had a higher specificity 
compared with Paracheck.Pf (P= 0.02) for P. falciparum detection. Sensitivity decreased with 
older age for both Vistapan [97.7% (under fives) vs 85.7%, P‹0.01] and Parabank[95.4%( 
under fives)vs73.1%, P‹0.001]. Sensitivity increased with axillary temperature≥ 37.5 0C at 
inclusion for Paracheck.Pf (98.8 vs91.4%, P=0.04), Vistapan(97.6 vs 89.0%, P=0.03) and 
Parabank(91.8vs81.0%, P=0.04) compared with patients with axillary temperature ‹37.5 0C. 
Although, the small number of non-falciparum monoinfections does not permit reliable 
calculations of validity of non-falciparum mutants, all tests detected 100 % (n=6) of the P. 
malariae monoinfections. Plasmodium vivax was detected in 4/6 infections by Carestart, 2/6 
by Vistapan and 1/6 by Parabank. 
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Parameters 
Group A
(<5yrs) 
Group B
(≥5yrs) Overall p-value 
Baseline characteristics n=239 n=221 n=460  
Gender ratio (M:F) 
0.98 
(118:121) 
0.52 
(76:145) 
0.72 
(194:266) 
0.001(X 2) 
Mean age(SD) 
2yrs 
(14 months) 
22yrs 
(12yrs) 
12yrs 
(13 yrs) 
N/A 
Median duration of 
illness in days (range) 
3(1-14) 3(1-30) 3(1-30) 
0.2(Kruskai-
Wallis) 
Previously taken 
antimalarial (n,%) 
81(33.9) 60(27.3) 141(30.7) 0.13( X 2) 
Fever on presentation 
(axillary temp≥ 37.5 0C) 99(41.4) 31(14.0) 130(28.3) <0.001(X 2) 
Parasitological 
characteristic 
n=129 n=119 n=248 ----------- 
Asexual parasitemia 
range (parasites/µl) 
16-703411 16-233241 16-703411 
0.001(Kruskal-
Wallis) 
Geometric mean of 
asexual 
parasitemia(95%Cl) 
7433(4869-
11346) 
1524(975-2384) 3475(2521-4790) 0.001(t test) 
Interquartile range 
(Interquartile value) 
1682-
45748(44066) 
166-
11070(10904) 
641-
23827(23186) 
---------- 
Gametocyte 
carriage(n,%) 
36(27.9) 22(18.5) 58(23.4) 0.11(X 2) 
Table 2. Baseline characteristics of all study subjects and Parasitological characteristics of Slide-positive 
subjects attending Mbarara Regional Referal Hospital, Outpatient department, South -Western Uganda 
Reliability 
The k statistic for the inter-reader reliability for all tests was above 0.90(very good 
agreement) [Carestart,k=0.96(95.0%, Cl 0.94—0.99); Vistapan, k=0.94( 95% Cl 0.91- t 0.97); 
Parabank, k=0.96(95% Cl 0.94-0.99); Paracheck.Pf, k=0.97(95% Cl 0.95-1.0)] 
Time to Negativity of RDTs. 
There were no positive blood films on follow up visits, and therefore, every positive RDT 
result on day 3,7 or 14 was considered a false positive result (Table 4). All three RDTs tested 
had significantly fewer false positive results on every day of follow-up compared with 
Paracheck.Pf(P‹0.001 for all tests on day 3,7 and 14). There was o difference between the 
pLDH tests by day 14, with the percentage of positive tests ranging from 4.6 to 9.5%. 
Younger age group and higher parasite level at inclusion were related to positive Paracheck. 
Pf on all follow-up days (logistic regression, P‹0.01), for all. Age group, fever at diagnosis 
and presence of gametocytes on day 3 were all related to a positive pLDH test on day 3 
(except age group for Parabank)(age group:Vistapan P=0.026, Carestart P‹0.001. 
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Parameters  
Carestart % 
[95 Cl] 
Vistapan% 
[95%Cl) 
Parabank% 
[95% cl) 
Paracheck 
=Pf%(95%cl) 
Sensitivity  
95.6(237/248) 
[90.2-96.6] 
91.9(228/248) 
[87.8-95] 
84.7(210/248) 
[79.6-88.9] 
94(233/248) 
[90.2-96.6] 
Specificity  
91.5(194/212) 
[86.9-94.9] 
89.6(190/212) 
[84.7-93.4] 
94.3(200/212) 
[90.3-97.0] 
87.3(185/212) 
[82.0-91.4] 
PPV  
92.9(237/255) 
[89.1-95.8] 
91.2(228/250) 
[87-94.4] 
94.6(210/222) 
[90.7-97.2] 
89.6(233/260) 
[85.3-93] 
NPV  
94.6(194/205) 
[90.6-97.3] 
90.5(190/210) 
[85.7-94.1] 
84.0(200/238) 
[78.7-88.4] 
92.5(185/200) 
[87.9-95.7] 
PPV: Positive Predictive Value; NPV: Negative Predictive Value 
Table 3. Validity of four rapid diagnostic tests for the detection P. falciiparum species in patients 
attending Mbarara Regional Hospital, out-patient department, southwestern Uganda 
 
RDT  Day 0 na Day 3% [95% Cl] Day 7 %[ 95Cl] Day 14 % [95% Cl] 
Paracheck -
Pf  
226 
86.2(193/224) 
[81.7-90.7] 
80.8(181/224) 
[75.6-86.0] 
69.7(152/218) 
[63.1-75.7] 
Vistapan  221 
36.1(79/219)[29.7-
42.5] 
3.4(51/218)[17.8-
29.0] 
8.9(19/213) 
[5.1-12.7] 
Carestart  230 
42.5(97/228) 
[36.1-48.9] 
27.6( 63/228) 
[21.8-33.4] 
9.5(21/221) 
[5.6-13.4] 
Parabank  204 
17.8(36/202) 
[12.5-23.1] 
8.9(18/202) 
[5.0-12.8] 
4.6(9/196) 
[1.7-7.5] 
 a n is the number of positive tests for each RDT on day 0 in patients who were followed up. 
Table 4. Percentage of positive tests on each follow up visit in patients attending Mbarara Regional 
Hospital, Outpatient department, SouthWestern Uganda. 
In overall, there are not large differences between the tests in terms of ease of use. Some tests 
have small advantages or disadvantages over others. For example, Vistapan has individual 
buffer sachets, considered to be an advantage, where as Carestart has a delay time of over 60 
seconds between blood application and buffer application, considered to be a disadvantage. 
All tests results are stable for a minimum of 24hr.The number of invalid tests was ‹0.5% for 
Parabank and between 0.5 and 2% for Carestart and Vistapan. No test had items requiring 
refrigeration and all tests have undergone temperature stability studies up to 30 0C. 
This study appears to be a pioneer study [17] to evaluate a new generation of pLDH tests for 
malaria diagnosis, performed in a mesoendemic African setting with a predominance of P. 
falciparum infections. The authors showed that several of these tests were validated and 
should be of great use in malaria endemic countries, where microscopy is not available and 
well trained microscopists are lacking. For confident diagnosis of malaria in routine 
outpatient departments, a sensitivity of more than 90% is crucial and this was achieved for 
Carestart and Vistapan. 
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The pLDH tests also demonstrated desirable qualities that could reduce the possibility of 
patients without malaria being treated or given antimalarial drugs, thereby reducing drug 
pressure and resistance, a major concern at a time when artemisinin combination therapy 
(ACTs) are being introduced throughout Africa. Their high specificity would reduce the 
number of patients with false positive results. Secondly, the great reduction in the number 
of tests remaining positive for a long time after treatment had been effected. This is 
reminiscent of the test carried out by HRP 2. Thirdly, the ability to detect both P. falciparum 
and P. vivax, would increase confidence on a negative test result. A variety of factors may 
contribute towards differing sensitivities of the test, such as patients age and level of 
parasitemia, which will vary according to endemic nature of P. falciparum in the locality. 
Lower test sensitivity may be related to low parasitemia in adults in an area of stable 
transmission. This may be a limitation of the tests; although, such patients are less at risk 
from severe clinical episodes to perpetuate parasite transmission. 
8. Comparison of two rapid field immunochromatographic tests to expert 
microscopy in malaria diagnosis. 
The vast majority of malarial tests adopted and used in the past depended on light 
microscopy and expertise in attaining results. Currently, the vast majority of malaria cases 
in the world are diagnosed by the century old standard of light microscopy and stained 
blood smears. Although the technique is sensitive and very inexpensive, there are several 
disadvantages. The disadvantages include practical issues such as electrical requirement, the 
need for experienced staff as well as difficulties in accurate species identification. Efforts 
have been made to develop malaria rapid diagnostic devices (MRDDs) to facilitate field 
diagnosis [18]. While the first generation tests diagnosed only Plasmodium falciparum, 
newer devices were designed to recognize both Plasmodium falciparum and P. falciparum 
specific antigen as well as Plasmodium genus specific antigen. 
The ICT malaria Pf/P.v test is a rapid immunochromatographic assay for the detection of P. 
falciparum-specific Pf HRP 2 and a pan-malarial antigen, manufactures in test card form. 
The name is misleading as the pan malarial antigen may be produced by Plasmodium ovale, 
and Plasmodium malariae as well. The test has been shown to be specific and sensitive. 
Malaria P.f/P.v test has been shown to be 96% sensitive and 90% specific for P. falciparum 
and 75% sensitive and 95% specific for P. vivax [19,20]. 
The OptiMAL dipstick test detects two forms of plasmodium lactate dehydrogenase 
parasites pLDH1; one P. falciparum-specific and one common to the four plasmodium 
species which infect humans. Many researchers reported a 95% sensitivity and 100% 
specificity for P. falciparum, and a 96 % sensitivity and 100% specificity for P.vivax. 
Sensitivity for P. ovale and P.malariae were significantly lower (57% and 47%) respectively. 
Using a batch OptiMAL dipstick procedure in 1999, a large scale field evaluation showed 
the following result: 91% sensitivity and 95% specificity for P.falciparum and 83% sensitivity 
and 100 % specificity for P.vivax [21]. 
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Methodology. The methodology involved the use of patients both symptomatic and 
asymptomatic , who are villagers referred to the study and informed consent obtained. For 
each patient, a finger prick was made and the following were obtained. Fifty microliters of 
blood in a pre-heparinized Eppendorf tube for dipstick assays and two thick/ thin smears, 
one for on –site microscopic diagnosis by Acridine orange(AO) technique (for immediate 
treatment purposes, and the other, for reference Geimsa-microscopist.OptiMAL reader and 
ICT reader, were all blinded to each other’s diagnosis. Patients positive for malaria were 
treated. Thick and thin blood smears were prepared and stained with Geimsa according to 
standard procedures. To declare a sample negative, thick smears were read for 200 
microscopic fields (1000 X) without finding a parasite.If found positive, the number of 
asexual malaria parasites were counted per 500 WBC separately for each species. If there are 
more than 250 parasites/500 WBC, parasites were counted on the corresponding thin film 
per 10,000RBC. Density calculations were based on approximations of7500 WBC/µl and 
5X10 6 RBC/µl. ICT malaria P.f/P.v test kits were used as per manufacturers instructions. 
Ten microliters (10µl) of whol blood was transferred to a sample pad. A buffer reagent was 
added to induce cell lysis and allow PfHRP 2 and pan malarial antigens to bind to colloidal 
gold-labeled antibodies. Additional buffer caused the blood and immune complexes to 
migrate up the test strip and cross monoclonal (mAb) lines. Finally, more buffer was added 
to clear blood from the membrane and facilitate reading. 
Tests are counted as valid, if control lines are observed. They were counted P. falciparum 
positive, if Pf HRP 2 specific and pan-malarial antigen lines were visible or if only PfHRP 2-
specific lines were seen only. If the control and pan-malarial antigen lines were observed, 
the sample was counted as positive for a malaria parasite other than P. falciparum. The test 
result was assigned a value of +0, if no line was seen; +1, if test line intensity was less than 
control line intensity; +2,if it was equal and +3, if it was greater in intensity. Other factors can 
exacerbate drug resistance. The second type of RDT detects the malarial antigen parasite-
lactate dehydrogenase (pLDH), an enzyme produced in the glycolytic pathway or cycle of 
the asexual stage of all species of plasmodium. Parasite lactate dehydrogenase is produced 
only by viable parasites, being cleared from the blood stream more quickly after treatment, 
resulting in the test becoming negative more quickly [22].  
9. Clinical and epidemological findings based on histopathology and 
immunohistochromatographic detection of p.falciparum antigens  
This new technique for determination of P.falciparum is not adopted during autopsy when 
actual diagnosis of P.falciparum infestation is missed mostly during improper diagnosis. 
Many organs and tissues manifest the severity of this type of malaria before death. The 
heart, lung, liver tissues are always available for post mortem analysis. Some other tissues 
used include: spleen, kidney, and brain. The following tissues were equally used in a case of 
five travelers suspected to have died from other chronic diseases not related to malaria. 
These other tissues include: tongue, trachea, thyroid and adrenal glands, gall bladder and 
testis. Viral and or bacterial hemorrhagic fever pathogens were suspected at death [23, 24, 
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25]. In the study, three novel IHC assays targeting HRP 2, aldolase, and pLDH were 
developed and confirmed on severe P. falciparum infection in five travelers whose deaths 
were wrongly suspected. 
Malaria is the most common cause of fever in travelers returning to industrialized cities or 
countries from malaria endemic countries. However, the clinical features of the disease are 
not specific and in some areas where P.falciparum is not endemic, fatal malaria is often not 
suspected. The pathological features of malaria resemble many other viral, rikettsial and 
bacterial infections. An unequivocal diagnosis can be made only by laboratory testing. IHC 
assays and histopathologic review confirmed P. falciparum infections in many study cases 
as being responsible for unsuspected deaths. Abundant hemozoin pigment, a by-product of 
parasite metabolism was distributed diffusely throughout peripheral tissues and in the 
blood vessels in the central nervous system. The findings are consistent with reports of 
hemozoin localization. The density of hemozoin increases in proportion to the duration of 
falciparum infestation and decreases with adequate and appropriate therapy. It has been 
discovered that the hallmark of P.falciparum infection is sequestration, characterized by the 
adherence of mature stage falciparum pRBCs(trophozoites and schizonts) to endothelial 
cells of capillaries and venules.  
Many studies in humans and other animals have described sequestration of trophozoites and 
schizonts in a variety of tissues, including the brain, heart, lung, skeletal muscles and 
subcutaneous tissues. As a result of sequestration, peripheral blood parasitemia, traditionally 
evaluated using Geimsa bood smear, may not give substantive correlative result in the 
pathogenesis of the severity of P. falciparum, hence,the severity of the infection may be under-
estimated. Plasmodium falciparum infection caused respiratory symptoms that resemble 
influenza like-illness in correlation with results from studies. There is pulmonary edema with 
intra-aveolar hyaline membranes and proteinaceous debri, associated with malarial antigens. 
Pulmonary edema is associated with high parasitemias and often leads to respiratory distress 
syndrome. Rust tinged urine described for several patients afflicted with this malaria, is 
associated with hyperbilirubinemia caused by erythrocyte destruction. In many cases of P. 
falciparum, malarial antigens can be detected in tubular epithelial cells in association with 
erythrocyte casts. The HRP 2 antibody used in this study was specific for P.falciparum, 
whereas the aldolase and the pLDH antibodies reacted with both P. falciparum and P. vivax. 
In conclusion, the current approach in the diagnosis and development of new drugs for the 
treatment of Plasmodium falciparum infections is quite novel and holds promise for the 
future. The ubiquitous nature of the enzyme, Lactate dehydrogenase especially, parasite 
lactate dehydrogease (pLDH) as malaria antigen, is indicative of the vital biochemical 
process of metabolism of pyruvate and lactate in microbial cells. The endemic nature of 
malaria in Africa and some Mediterranean countries poses a great challenge to humanity. 
There should be a more radical approach especially in Africa and other countries afflicted to 
tackle this problem which tend to decimate world population. Other frontline drugs which 
are designed to inhibit the enzyme should be developed to add to the success of this 
protocol. In as much as mosquitoes have developed resistance against chloroquine, the drug 
in some places remains the only option for radical cure of malaria.  
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